Bitte beachten Sie, dass die von Ihnen aufgerufene Seite nicht in Ihrer Standardsprache vorliegt. Sie nutzen unsere Plattform nun in einer anderen Sprache.

Current and future value for pure play pharmaceutical companies 2005-2013

Published by Statista Research Department, Jan 15, 2014
This graph shows the current and future value for pure play pharmaceutical peer set from 2005 to 2013. The future value followed a constant downwards trend. In 2007, the future value increased some 255 billion dollars. After that, since 2008, the future value decreased constantly.

Current and future value for pure play pharmaceutical peer set from 2005 to 2013 (in billion U.S. dollars)*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2014

Region

Worldwide

Survey time period

2005 to October 2013

Supplementary notes

* 16 pure play biopharma companies only. Japanese companies have March year end (YE12 = Mar-13). Constant USD FOREX used from December 2012.

Citation formats
Use Statista now: Unlimited Access to All Statistics! $199 USD / Month
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

9

Other regions

9

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

SanofiGlobal pharmaceutical industryTop pharmaceutical drugsPfizerNovartis
All features, all contents, at all times: Learn more about our professional solutions.
Learn more about how Statista can support your business.
Menu